IP Library Granted Patent US 9,706,944
Granted Patent B2
US 9,706,944 · App. 14/667,539 · Granted Jul 18, 2017

Apparatus and method for simulating inhalation efforts

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,706,944
App. No.
14/667,539
Granted
Jul 18, 2017
Kind
B2
Abstract

An inhalation simulation system is provided for use with inhalers in particular breath-powered dry powder inhalers. The simulation system can recreate a patient's inhalation profile obtained with an inhaler adapted with a sensing and monitoring device for the detection of characteristic signals generated from the inhaler in use, which signals are transmitted to a computer with an algorithm which is configured to analyze the signals and generate new signals via a transmitter to actuate the inhalation simulation system component parts so that a subject's inhalation profile is replicated simultaneously or in real-time, or stored for later use. Methods of measuring the performance of inhalers are also provided.

Claims (31)

1. An apparatus comprising:

a first acoustic sensor in communication with a first breath-powered dry powder inhaler, the first sensor configured to monitor an inhalation maneuver of a patient and transmit a signal corresponding to the inhalation maneuver;

a processing device comprising a microprocessor and a storage medium having an algorithm stored therein, the device configured to receive the signal from the first sensor and processing the signal using the algorithm to generate a data set that is analyzed, stored, printed, transmitted, and/or displayed;

a controller that receives the data set and in turn controls a motor that is attached to a calibrated syringe pump that upon actuation by the controller generates a pressure differential in a second breath-powered dry powder inhaler that is attached to an anatomically correct artificial airway;

a display in communication with the processing device and configured to graphically display both the inhalation maneuver and data collected as a result of the pressure differential, wherein the pressure differential is modeled after the inhalation maneuver.

2. The apparatus of claim 1 , wherein the first sensor is located within the first inhaler or configured to attach to the first inhaler.

3. The apparatus of claim 1 , wherein the first inhaler and the second inhaler are breath-powered dry powder inhalers each comprising a sensor and a microprocessor built within the respective inhalers or provided in a device attachable to the inhalers.

4. The apparatus of claim 1 , wherein the first sensor is a microphone.

5. The apparatus of claim 1 , wherein the second inhaler comprises a cartridge comprising a dry powder for pulmonary delivery.

6. The apparatus of claim 5 , wherein the cartridge comprises a dry powder comprising diketopiperazine microparticles.

7. The apparatus of claim 6 , wherein the dry powder comprises at least one active ingredient.

8. The apparatus of claim 7 , wherein the at least one active ingredient comprises insulin, GLP-1, growth hormone, sumatriptan, parathyroid hormone, or analogs thereof.

9. The apparatus of claim 6 , wherein the first sensor is configured to transmit the signal by wire or wireless communication mode to the processing device.

10. The apparatus of claim 6 , wherein an analog to digital converter communicates the signal to the microprocessor that is configured to analyze and process the signal.

11. The apparatus of claim 6 , further comprising a signal conditioning circuitry and a wired or wireless communication interface.

12. The apparatus of claim 6 , wherein data generated from the signal are processed by the microprocessor to generate a data set that recreates the patient's inhalation profile.

13. The apparatus of claim 6 , wherein the first and second inhalers are structurally identical.

14. The apparatus of claim 5 , wherein the dry powder comprises at least one active ingredient.

15. The apparatus of claim 14 , wherein the at least one active ingredient comprises insulin, GLP-1, growth hormone, sumatriptan, parathyroid hormone, or analogs thereof.

16. A method for simulating an inhalation maneuver by a subject, the method comprising:

monitoring the inhalation maneuver by way of a first acoustic sensor located in or attached to a first breath-powered dry powder inhaler;

transmitting a signal generated by the first acoustic sensor to a device comprising a microprocessor and a storage medium having an algorithm stored therein;

processing the signal using the algorithm to generate a data set; and

performing the following with the data set:

storing the data set in the storage medium, and

transmitting the data set in the form of a second signal to a controller configured to control a motor that is attached to a calibrated syringe pump that upon actuation by the controller generates a pressure differential in a second breath-powered dry powder inhaler that is attached to an anatomically correct artificial airway,

wherein the pressure differential is modeled after the inhalation maneuver.

17. The method of claim 16 , wherein the airway is configured with a mouth connected to the second inhaler.

18. The method of claim 16 , wherein the first inhaler is adapted with a radio transmitter.

19. The method of claim 16 , wherein the first inhaler is adapted with a wireless or wired jacket comprising a microphone that can convert a sound signal generated within the first inhaler into an electrical impulse configured to communicate with a radio signal receiver that is in communication with the microprocessor.

20. The method of claim 16 , wherein the first and second inhalers are structurally identical.

Assignments (5)
PATENT SECURITY AGREEMENT Recorded Aug 12, 2025
From: MANNKIND CORPORATION
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 072444/0525 →
RELEASE OF SECURITY INTEREST Recorded Apr 5, 2024
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: MANNKIND CORPORATION; MANNKIND LLC
Reel/Frame 067024/0082 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2019
From: DEERFIELD PRIVATE DESIGN FUND II, L.P.; DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.; HORIZON SANTE FLML SARL
To: MANNKIND CORPORATION
Reel/Frame 050044/0138 →
SECURITY INTEREST Recorded Aug 13, 2019
From: MANNKIND CORPORATION; MANNKIND LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 050044/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2015
From: ADAMO, BENOIT; POLIDORO, JOHN M.; OVERFIELD, DENNIS; SAHI, CARL R.; LAURENZI, BRENDAN; SMUTNEY, CHAD C.; KINSEY, P. SPENCER
To: MANNKIND CORPORATION
Reel/Frame 036084/0264 →